Analysis of sigma receptor (σR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice

Molecular Brain Research

Volumn 107, Issue 2, 2002, Pages 97-107

  Shamsul Ola, M ^a   Moore, Pamela ^a   Maddox, Dennis ^a   El Sherbeny, Amira ^a   Huang, Wei ^a   Roon, Penny ^a   Agarwal, Neeraj ^b   Ganapathy, Vadivel ^a   Smith, Sylvia B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Diabetes; Diabetic retinopathy; Retina; Retinal ganglion cells; Sigma receptor

Indexed keywords

GLUCOSE; MANNITOL; MESSENGER RNA; SIGMA 1 OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINA GANGLION CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RATS; RECEPTORS, SIGMA; RETINAL GANGLION CELLS; RNA, MESSENGER;

EID: 0037111911     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00444-8     Document Type: Article

References (49)

1. Ambati J., Chalam K.V., Chawla D.K., D'Angio C.T., Guillet E.G., Rose S.J., Vanderlinde R.E., Ambati B.K. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch. Ophthalmol. 115:1997;1161-1166.
2. Bank N., Aynedjian H.S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 43:1993;1306-1312.
3. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102:1998;783-791.
4. Bhardwaj A., Sawada M., London E.D., Koehler R.C., Traystman R.J., Kirsch J.R. Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke. 29:1998;2404-2411.
5. Bowen W.D. Sigma receptors: recent advances and new clinical potentials. Pharm. Acta Helv. 74:2000;211-218.
6. Bresnick G.H. Diabetic retinopathy viewed as a neurosensory disorder. Arch. Ophthalmol. 104:1986;989-990.
7. Carter C., Benavides J., Legendre P., Vincent J.D., Noel F., Thuret F., Lloyd K.G., Arbilla S., Zivkovic B., MacKenzie E.T. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II: evidence for N-methyl-D-aspartate σ-receptor antagonist properties. J. Pharmacol. Exp. Ther. 247:1988;1222-1232.
8. DeCoster M.A., Klette K.L., Knight K.S., Tortella S.C. σ receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671:1995;45-53.
9. Engerman R.L., Kern T.S. Retinopathy in animal models of diabetes. Diabetes Metab. Rev. 11:1995;109-120.
10. Engerman R.L. Pathogenesis of diabetic retinopathy. Diabetes. 38:1989;1203-1206.
11. Ferris C.D., Hirsch D.J., Brooks B.P., Snyder S.H. σ receptors: from molecule to man. J. Neurochem. 57:1991;729-737.
12. Ghirlanda G., Di Leo M.A., Caputo S., Cercone S., Greco A.V. From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab. Rev. 1:1997;15-35.
13. Goyagi T., Goto S., Bhardwaj A., Dawson V.L., Hurn P.D., Kirsch J.R. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke. 32:2001;1613-1620.
14. Hanner M., Moebius F.F., Flandorfer A., Knaus H.G., Striessnig J., Kempner E., Glossmann H. Protein purification, molecular cloning, and expression of the mammalian sigma 1-binding site. Proc. Natl. Acad. Sci. USA. 93:1996;8072-8077.
15. Harukuni I., Bhardwaj A., Shaivitz A.B., DeVries A.C., London E.D., Hurn P.D., Traystman R.J., Kirsch J.R., Faraci F.M. Sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke. 4:2000;976-982.
16. Hayashi T., Su T.-P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc. Natl. Acad. Sci. USA. 98:2001;491-496.
17. Iadecola C., Pelligrino D.A., Moskowitz M.A., Lassen N.A. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 2:1994;175-192.
18. Jbilo O., Vidal H., Paul R., De Nys N., Bensaid M., Silve S., Carayon P., Davi D., Galiegue S., Bourrie B., Guillemot J.C., Ferrara P., Loison G., Maffrand J.P., Le Fur G., Casellas P. Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase. J. Biol. Chem. 272:1997;27107-27115.
19. Klette K.L., DeCoster M.A., Moreton J.E., Tortella F.C. Role of calcium in sigma-mediated neuroprotection in rat primary cortical cultures. Brain Res. 704:1995;31-41.
20. Komers R., Allen T.J., Cooper M.E. Role of endothelium-derived nitric oxide in the pathogenesis of renal hemodynamic changes of experimental diabetes. Diabetes. 43:1994;1190-1197.
21. Kowluru R.A. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetol. 38:2001;179-185.
22. Kowluru R.A., Engerman R.L., Case G.L., Kern T.S. Retinal glutamate in diabetes and effect of antioxidants. Neurochem. Int. 38:2001;385-390.
23. Krishnamoorthy R.R., Agarwal P., Prasanna G., Vopat K., Lambert W., Sheedlo H.J., Pang I.H., Shade D., Wordinger R.J., Yorio T., Clark A.F., Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Mol. Brain Res. 86:2001;1-12.
24. Largent B.L., Gundlach A.L., Snyder S.H. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238:1986;739-748.
25. Lieth E., Barber A.J., Xu B., Dice C., Ratz M.J., Tanase D., Strother J.M. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes. 47:1998;815-820.
26. Lieth E., Gardner T.W., Barber A.J., Antonetti D.A. Retinal neurodegeneration: early pathology in diabetes. Clin. Exp. Ophthalmol. 28:2000;3-8.
27. Lobner D., Lipton P. σ-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci. Lett. 117:1990;169-174.
28. Lockhart B.P., Soulard P., Benicourt C., Privat A., Junien J.-L. Distinct neuroprotective profiles for σ-ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675:1995;110-120.
29. Lorenzi M., Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia. 44:2001;791-804.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
31. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
32. Mizutani M., Gerhardinger C., Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes. 47:1998;445-449.
33. Moebius F.F., Striessnig J., Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharm. Sci. 18:1997;67-70.
34. 3 dorsal hippocampus. II. Involvement of a subtype of sigma receptors. J. Pharmacol. Exp. Ther. 263:1992;1219-1225.
35. Naggar H., Ola M.S., Moore P., Huang W., Bridges C.C., Ganapathy V., Smith S.B. Downregulation of the reduced-folate transporter by glucose in cultured retinal pigment epithelial cells and in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Vis. Sci. 43:2002;556-563.
36. Nishikawa H., Hashino A., Kume T., Katsuki H., Kaneko S., Akaike A. Involvement of direct inhibition of NMDA receptors in the effects of sigma-receptor ligands on glutamate neurotoxicity in vitro. Eur. J. Pharmacol. 404:2000;41-48.
37. Ola M.S., Moore P., El-Sherbeny A., Roon P., Agarwal N., Sarthy V.P., Casellas P., Ganapathy V., Smith S.B. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Mol. Brain Res. 95:2001;86-95.
38. Parisi V., Uccioli L., Monticone G., Parisi L., Manni G., Ippoliti D., Menzinger G., Bucci M.G. Electrophysiological assessment of visual function in IDDM patients. Electroencephalogr. Clin. Neurophysiol. 104:1997;171-179.
39. Schmetterer L., Findl O., Fasching P., Ferber W., Strenn K., Breiteneder H., Adam H., Eichler H.G., Wolzt M. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes. 46:1997;653-658.
40. 1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur. J. Pharmacol. 342:1998;105-111.
41. Senda T., Matsuno K., Mita S. The presence of σ receptor subtypes in bovine retinal membranes. Exp. Eye Res. 64:1997;857-860.
42. Seth P., Fei Y.-J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of a σ receptor from rat brain. J. Neurochem. 70:1998;922-931.
43. Seth P., Ganapathy M.E., Conway S.J., Bridges C.C., Smith S.B., Casellas P., Ganapathy V. Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand binding domain of the receptor. Biochim. Biophys. Acta. 1540:2001;59-67.
44. Seth P., Leibach F.H., Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine Type 1 sigma receptor. Biochem. Biophys. Res. Commun. 241:1997;535-540.
45. Su T.P., London E.D., Jaffe J.H. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science. 240:1988;219-221.
46. Takahashi H., Traystman R.J., Hashimoto K., London E.D., Kirsch J.R. Postischemic brain injury is affected stereospecifically by pentazocine in rats. Anesth. Analg. 85:1997;353-357.
47. Wu G. Diabetic retinopathy. Retina: The Fundamentals. 1995;31 WB Saunders, Philadelphia, PA.
48. Yamamoto H., Yamamoto T., Sagi N., Klenerova V., Goji K., Kawai N., Baba A., Takamori E., Moroji T. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J. Neurosci. 15:1995;731-736.
49. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263:1994;687-689.